Clinical Trials Browser

Phase 2 × Extensive Stage Small Cell Lung Cancer × Bevacizumab × Clear all

NCT00118235 2014-06-17

Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer

Phase 2 Completed

Extensive Stage Small Cell Lung Cancer

NCT00079040 2014-05-14

Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer

Phase 2 Completed

65 enrolled 7 charts

Extensive Stage Small Cell Lung Cancer